Orbimed Advisors Llc - May 9, 2025 SCHEDULE 13D/A Report for Edgewise Therapeutics, Inc. Common Stock (EWTX)

Filing Manager
ORBIMED ADVISORS LLC
Reporting Manager
ORBIMED ADVISORS LLC
Security
Edgewise Therapeutics, Inc. Common Stock
Symbol
EWTX
Shares outstanding
105M shares
Disclosed Ownership
15.3M shares
Ownership
14.5%
Form type
SCHEDULE 13D/A
Date filed
5/12/2025, 07:13 PM
Date of event
May 9, 2025
SEC
View on sec.gov

Reporting Managers (4)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
ORBIMED ADVISORS LLC 14.5% 15.3M 0 15.3M /s/ Carl L. Gordon Carl L. Gordon/Member 0001055951
ORBIMED CAPITAL GP VI LLC 14.1% 14.8M 0 14.8M /s/ Carl L. Gordon Carl L. Gordon/Member of OrbiMed Advisors LLC (ORBIMED ADVISORS LLC, its managing member) 0001682115
OrbiMed Genesis GP LLC 0.4% 444K 0 444K /s/ Carl L. Gordon Carl L. Gordon/Member of OrbiMed Advisors LLC (ORBIMED ADVISORS LLC, its managing member) 0001808744
ORBIMED CAPITAL LLC 0.3% 266K 266K 0 /s/ Carl L. Gordon Carl L. Gordon/Member 0001157524